| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 145, 1127-1139, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
Z Qu, M Picou, TT Dang, E Angell, SR Planck, CE Hart and JT Rosenbaum
Department of Cell Biology and Anatomy, Casey Eye Institute, Oregon Health Sciences University, Portland 97201.
A prerequisite in defining the role of a growth factor in a disease is knowledge of its expression kinetics during the natural course of the disease. We, therefore, used immunohistochemical and immunoblot analyses to examine tissue distribution of basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF-A) during the development of destructive arthropathy in the rat adjuvant arthritis model. In normal joints, bFGF was primarily localized in endothelial cells. In inflamed joints, increased staining for bFGF was found in the invading panni, hyperplastic synovium, and thickened periosteum where bFGF was also co-localized with two cell proliferation markers. Staining for bFGF began to increase at the onset of arthritis (days 11 to 13), reached peak level on days 17 to 24, and gradually declined afterward. In contrast, PDGF-A staining did not change until day 17 and the increased staining was restricted to areas of newly formed bone. The district temporal and spatial distribution pattern of these two growth factors during the destructive arthropathy strongly suggests that they play different roles during arthritis. Although PDGF-A seems to be exclusively related to osteogenesis, bFGF may have a more extensive impact on synovial proliferation and bone destruction as well as bone formation.
This article has been cited by other articles:
![]() |
H. Lappalainen, P. Laine, M. O. Pentikainen, A. Sajantila, and P. T. Kovanen Mast Cells in Neovascularized Human Coronary Plaques Store and Secrete Basic Fibroblast Growth Factor, a Potent Angiogenic Mediator Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1880 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamashita, Y. Yonemitsu, S. Okano, K. Nakagawa, Y. Nakashima, T. Irisa, Y. Iwamoto, Y. Nagai, M. Hasegawa, and K. Sueishi Fibroblast Growth Factor-2 Determines Severity of Joint Disease in Adjuvant-Induced Arthritis in Rats J. Immunol., January 1, 2002; 168(1): 450 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Manabe, H. Oda, K. Nakamura, Y. Kuga, S. Uchida, and H. Kawaguchi Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients Rheumatology, August 1, 1999; 38(8): 714 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Liu, G. F. Morris, W.-H. Lei, C. E. Hart, J. A. Lasky, and A. R. Brody Rapid Activation of PDGF-A and -B Expression at Sites of Lung Injury in Asbestos-exposed Rats Am. J. Respir. Cell Mol. Biol., August 1, 1997; 17(2): 129 - 140. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |